In 2021, the World Health Organization solely defined glioblastoma as an IDH wild-type WHO grade IV astrocytoma, while the IDH-mutant counterpart is designated as a WHO Grade IV astrocytoma or oligodendroglioma [5]. The gene discussed is IDH2; the disease is oligodendroglioma.